Abstracts tagged "fibromyalgia"

Abstract Number: 2291 • 2015 ACR/ARHP Annual Meeting
The Factors That Might be Responsible for the Improvement of Fibromyalgia Patients: A Sub-Group That Improved Significantly over Three to Six Months
Robert S. Katz¹ and Lauren Kwan², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: In a rheumatology office practice, patients with fibromyalgia who improved significantly in their symptoms are seen commonly. We evaluated patients whose pain, fatigue, fibrofog,…
Abstract Number: 3086 • 2015 ACR/ARHP Annual Meeting
The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
Kathryn A. Gibson¹, Annie Huang² and Theodore Pincus², ¹Liverpool Hospital, Liverpool, Australia, ²Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: An MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) is a 2 sided, 1 page questionnaire which is completed by patients in…
Abstract Number: 2294 • 2015 ACR/ARHP Annual Meeting
Re-Scoring the 2011 Fibromyalgia Survey Criteria to be a Better Surrogate for Pain Centralization
Stephanie Moser¹, Chad Brummett², Alexander Tsodikov³, David A. Williams⁴ and Daniel J. Clauw², ¹Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, ⁴Anesthseiology, University of Michigan, Ann Arbor, MI
Background/Purpose: The 2011 Fibromyalgia (FM) Survey Criteria is comprised of measures of widespread pain (0-19 body areas) and 6 co-morbid symptoms (scored 0-12). The measure…
Abstract Number: 3090 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients
Hyein Kim¹, Jing Cui², M Frits³, C Iannaccone⁴, Jonathan S. Coblyn³, N Shadick⁵, Michael Weinblatt⁴ and Yvonne C. Lee⁶, ¹Western University, London, ON, Canada, ²Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ³Brigham & Women's Hospital, Boston, MA, ⁴Brigham and Women's Hospital, Boston, MA, ⁵Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁶Rheumatology Immunology & Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: The prevalence of fibromyalgia (FM) is 10-20% in rheumatoid arthritis (RA) patients, compared to 2-3% in the general population. Previous studies have shown that…
Abstract Number: 70 • 2015 ACR/ARHP Annual Meeting
Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014
Jose Eduardo Martinez^1,2, Marcelo C. Rezende^3,4, Eduardo Paiva^4,5, Daniel Pollak^4,6, Milton Helfenstein Jr^4,7, Jose Roberto Provenza^4,8, Aline Ranzolin^4,9, Roberto E Heymann^4,10, Eduardo L. Ribeiro^4,11, Marcos Renato Assis^4,12 and Eduardo J. R. Souza^4,13, ¹Sociedade Brasileira de Reumatologia, Sorocaba, Brazil, ²Medicine, Pontifical Catholic University of Sao Paulo, Sorocaba, Brazil, ³Santa Casa de Campo Grande, Campo Grande, Brazil, ⁴Sociedade Brasileira de Reumatologia, São Paulo, Brazil, ⁵Rheumatology, Universidade Federal do Parana, Curitiba, Brazil, ⁶Rheumathology, Universidade Federal de São Paulo, São Paulo, Brazil, ⁷RUA JOAO DE LACERDA SOARES, 90, Unifesp, Sao Paulo, Brazil, ⁸Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, ⁹Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ¹⁰Universidade Federal de São Paulo, São Paulo, Brazil, ¹¹Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, ¹²Faculdade de Medicina de Marilia, Marilia, Brazil, ¹³Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
Background/Purpose: –The Brazilian registry on fibromyalgia syndrome (EPIFIBRO) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
Abstract Number: 2299 • 2015 ACR/ARHP Annual Meeting
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
Yi-Rang Yim¹, Dong-Jin Park², Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim⁹, Hye-Soon Lee¹⁰, Hyoun-Ah Kim¹¹, Chung-Il Joung¹², Sang-Hyon Kim¹³ and Shin-Seok Lee¹, ¹Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ³Inje University Haeundae Paik Hospital, Busan, South Korea, ⁴Soonchunhyang University, College of Medicine, Cheonan, South Korea, ⁵Internal Medicine, Maryknoll Medical Center, Busan, South Korea, ⁶Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, ⁹Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, ¹⁰Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹¹Ajou University Hospital, Suwon, South Korea, ¹²Internal Medicine, Konyang University Medical School, Daejeon, South Korea, ¹³Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Background/Purpose: Although polymorphisms of the catechol-O-methyl transferase (COMT) gene have been implicated in altered pain sensitivity, results concerning the association between COMT gene polymorphisms and…
Abstract Number: 3091 • 2015 ACR/ARHP Annual Meeting
A Randomized, Controlled Trial of Pregabalin in Adolescent Patients (12-17 years) with Fibromyalgia
Lesley Arnold¹, Lucinda Bateman², Kenneth N. Schikler³, Tahira Khan⁴, Lynne Pauer⁴, Pritha Bhadra Brown⁵, Marci L. Chew⁴, Andrew Clair⁵ and Joseph Scavone⁴, ¹University of Cincinnati, Cincinnati, OH, ²Bateman Horne Center, Salt Lake City, UT, ³Pediatrics, University of Louisville, Louisville, KY, ⁴Pfizer Inc, Groton, CT, ⁵Pfizer Inc., New York, NY
Background/Purpose: :Fibromyalgia (FM) is characterized by chronic widespread pain, sleep disturbance, and fatigue. Pregabalin is approved in the US in adults for the management of…
Abstract Number: 3011 • 2014 ACR/ARHP Annual Meeting
Ambulatory Gait Analysis in Clinical Practice: Single or Dual Task Conditions?
Bernard Auvinet¹, Claude Touzard² and Vincent Goëb³, ¹Rheumatology Unit, Polyclinic, LAVAL, France, ²Gerontology Unit, Hospital of Laval, LAVAL, France, ³Rheumatology, Amiens University Hospital, Amiens, France
Background/Purpose Interest in ambulatory gait analysis is increasing thanks to validated gait analysis apparatus dedicated to clinical practice. Such methodology has to be reproducible, sensitive,…
Abstract Number: 1881 • 2014 ACR/ARHP Annual Meeting
Patients Who Fail Biologics Are More Likely to Have Concomitant Fibromyalgia
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: One area not assessed by studies to evaluate the efficacy of new medications in patients with inflammatory arthritis is whether the patient may have…
Abstract Number: 2338 • 2014 ACR/ARHP Annual Meeting
Cost-Effectiveness and Yield of Different Recruitment Strategies Utilized in an Exercise Trial of Fibromyalgia Patients
Anna Schmid¹, William F. Harvey¹, Lori Lyn Price² and Chenchen Wang¹, ¹Rheumatology, Tufts Medical Center, Boston, MA, ²Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Background/Purpose In a large-scale clinical trial with a long-term outcome, it is essential to use recruitment strategies that are both cost-effective and likely to yield…
Abstract Number: 1384 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia and Its Effect on Treatment Response in Early Rheumatoid Arthritis Patients
Josefina Durán Santa Cruz¹, Bernard Combe², Jingbo Niu¹, Nathalie Rincheval³, Cécile Gaujoux-Viala⁴ and David T. Felson⁵, ¹Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ²Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ³Institut Universitaire de Recherche Clinique, Montpellier, France, ⁴EA 2415, Montpellier I University, Nîmes University Hospital, Rheumatology Department, Nîmes, France, ⁵Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Fibromyalgia (FM) occurs commonly in patients with rheumatoid arthritis (RA) and its effect on treatment response is unknown. In this study we aimed to…
Abstract Number: 2083 • 2014 ACR/ARHP Annual Meeting
Evaporative Dry-Eye Disease and Aqueous Deficient Dry-Eye Disease Associated with Fibromyalgia
William Pachas¹, Jack Greiner^2,3,4,5 and Paula Oliver^2,3,4,6, ¹Center for Rheumatology, Osteoporosis and Fibromyalgia, Boston, MA, ²The Schepens Eye Research Institute, Boston, MA, ³Massachusetts Eye and Ear Infirmary, Boston, MA, ⁴Harvard Medical School, Boston, MA, ⁵The Boston Ocular Surface Center, Boston, ME, ⁶The Boston Ocular Surface Center, Boston, MA
Background/Purpose Fibromyalgia (FM) patients with ocular discomfort often describe symptoms characteristic of dry eye diseases, but frequently do not fulfill criteria diagnostic of Sjögrens syndrome.…
Abstract Number: 1337 • 2014 ACR/ARHP Annual Meeting
Mindfulness Is Associated with Symptom Severity and Pain Impact in Patients with Fibromyalgia
Emily Wolcott¹, William F. Harvey², Lori Lyn Price³, Jeffrey B. Driban², Nani Morgan⁴, Lucas Morgan¹ and Chenchen Wang², ¹Tufts Medical Center, Boston, MA, ²Rheumatology, Tufts Medical Center, Boston, MA, ³Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ⁴Internal Medicine Residency Program, University of Hawaii, Honolulu, HI
Background/Purpose: Mindfulness is attention to and awareness of present experiences (e.g. physical sensations, emotions, thoughts) in a nonjudgmental way. Initial evidence suggests that increased mindfulness…
Abstract Number: 2077 • 2014 ACR/ARHP Annual Meeting
A New Tender Point on the Plantar Arch in Primary Juvenile Fibromyalgia: A Potential Point to be Considered
Walter J. Spindler¹, Cecilia Santarelli², Alberto J. Spindler², Alberto Berman², Horacio Berman² and Mirta Santana², ¹Tucuman, Centro Medico Privado de Reumatologia, Tucuman, Argentina, ²Centro Medico Privado de Reumatologia, Tucuman, Argentina
Background/Purpose Juvenile Primary Fibromyalgia Syndrome (JPFS) is a chronic and complex musculoskeletal disorder that may cause diffuse pain accompanied by defined tender points. Diagnostic dilemmas…
Abstract Number: 1117 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Patients Taking Opioids Have Low Self-Efficacy and High Pain Catastrophizing but No Reduction in Pain or Improvement in Activity
Joseph Adu¹, Cecilia P. Chung¹, Li Alemo Munters^1,2, Leon Darghosian¹, Rebecca Spitz³, Dana Dailey³, Barbara Rakel^3,4, Kathleen Sluka^4,5 and Leslie J. Crofford⁶, ¹Medicine, Vanderbilt University, Nashville, TN, ²Medicine, Karolinska Institute, Stockholm, Sweden, ³Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, ⁴College of Nursing, University of Iowa, Iowa City, IA, ⁵Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, IA, ⁶Div of Rheumatology & Immunology, Vanderbilt University, Nashville, TN
Background/Purpose: Fibromyalgia (FM) is a chronic disease of unknown etiology characterized by diffuse pain leading to fatigue, unrefreshing sleep and mood disturbances. The Fibromyalgia Activity…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].